BridgeBio Pharma Inc (BBIO)
30.92
+0.06
(+0.19%)
USD |
NASDAQ |
Mar 28, 16:00
30.89
-0.03
(-0.10%)
After-Hours: 20:00
BridgeBio Pharma Total Assets (Quarterly): 546.38M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 546.38M |
September 30, 2023 | 655.01M |
June 30, 2023 | 503.66M |
March 31, 2023 | 625.68M |
December 31, 2022 | 623.04M |
September 30, 2022 | 728.74M |
June 30, 2022 | 862.23M |
March 31, 2022 | 813.15M |
December 31, 2021 | 1.013B |
September 30, 2021 | 781.52M |
June 30, 2021 | 1.081B |
Date | Value |
---|---|
March 31, 2021 | 1.093B |
December 31, 2020 | 703.59M |
September 30, 2020 | 787.69M |
June 30, 2020 | 905.23M |
March 31, 2020 | 989.80M |
December 31, 2019 | 631.68M |
September 30, 2019 | 640.53M |
June 30, 2019 | 325.54M |
March 31, 2019 | 401.37M |
December 31, 2018 | 464.94M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
325.54M
Minimum
Jun 2019
1.093B
Maximum
Mar 2021
735.62M
Average
716.16M
Median
Total Assets (Quarterly) Benchmarks
Pfizer Inc | 226.50B |
Alnylam Pharmaceuticals Inc | 3.830B |
Shockwave Medical Inc | 1.567B |
Cytokinetics Inc | 824.32M |
Sarepta Therapeutics Inc | 3.265B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.889B |
Shareholders Equity (Quarterly) | -1.354B |
Debt to Equity Ratio | -1.275 |
Current Ratio | 3.320 |
Net Debt Paydown Yield | -0.08% |